Fig. 3From: A randomized, double-blind, placebo-controlled, multicenter study assessing the efficacy of magnesium oxide monohydrate in the treatment of nocturnal leg crampsAnalysis of the Secondary Efficacy Parameters. Secondary efficacy parameters are presented as calculated at each study visit for each study group (Placebo (N = 87) – blue, MOMH (N = 86) – red). A. Mean NLC episode duration (left, MOMH N = 86), NLC-related pain (middle), Sleep quality (right). Reduction in these parameters indicates improvement. B. Quality of life parameters – Physical functioning (top left), Role limitation due to physical health (top middle), Role limitation due to emotional problems (top right), Vitality (middle left), Mental health (middle), Social functioning (middle right), Body pain (bottom left), General health (bottom right). Increased values indicate improvementBack to article page